Propanc Biopharma, Inc. (PPCB)
Nasdaq: PPCB · Pharmaceutical Preparations · Camberwell, Victoria, AU · filing with the SEC since 2011
Filings
310 filings since 2017 beside 7 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.
Filings a yearinsider forms included
3744172737244133
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Oct 29, 2026.Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Jul 14, 2026.SEC letters: 17 in the last 36 months, the newest Apr 16, 2026.A late-filing notice, Form NT 10-Q, filed Feb 14, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2025
8-K items 3.02, 5.03, 9.01
Shares sold without registration; Charter, bylaw or fiscal-year change · Current report
Nov 4, 2025
40 of 310 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.